Led by Dr. Allama Elmehdi, physician and health economist
Health advisory for the GCC and Africa
Health projects, made financeable.
NexuOneSC helps governments, healthcare investors and innovators turn health needs into projects that are feasible, compliant and ready for a financing decision.
- Led by
- A physician and health economist
- Working in
- English, French and Arabic
- Across
- Feasibility, PPPs and regulation
Who we work with
Each client arrives with a different decision to make. Choose yours to see the problems we solve and what you can commission.
Governments and public-health institutions
You need new capacity, such as a hospital, a specialised service or a financing reform, and the budget cannot carry it alone.
What you can commission
- Feasibility and business cases for new facilities
- PPP readiness and structuring options
- Health financing and efficiency reviews
- Regional financing models for high-cost care
Health systems and public-private partnershipsHealthcare investment and feasibility
Healthcare investors and development organisations
You see promising health projects in the GCC and Africa, but need to know which ones are genuinely bankable and what could go wrong.
What you can commission
- Independent feasibility and model review
- Regulatory and integrity due diligence
- Market and demand assessment
- Partnership and risk-allocation analysis
Healthcare investment and feasibilityRegulatory strategy and market access
Hospital groups and healthcare operators
You are planning expansion, a new service line or a partnership with government, and the economics must hold over many years.
What you can commission
- Service-line business cases
- Workforce-aware financial models
- Partnership proposals to public payers
- Executive briefings for boards
Healthcare investment and feasibilityHealth systems and public-private partnerships
Pharmaceutical, biotechnology and MedTech companies
Your product must clear demanding regulators and reach patients in markets with very different pricing and access rules.
What you can commission
- Regulatory pathway strategy (FDA, EMA, EU MDR, SaMD)
- Compliance-by-design programmes for AI and robotics
- Pricing and market-access assessment for MENA
- Local manufacturing and technology-transfer feasibility
Regulatory strategy and market accessHealthcare investment and feasibility
Universities, conference organisers and collaborators
You want an expert voice who can connect medicine, economics and regulation for an informed audience.
What you can commission
- Keynotes, panels and moderation
- Training in health economics and financing
- Research and programme collaboration
- Mentoring and curriculum input
From health need to a decision-ready project
Most health projects stall between a convincing need and a case that financiers and regulators can approve. We work across that gap.
-
Define the need
Who will be served, with what model of care, and at what scale. The service drives the design, not the building.
-
Test feasibility
Demand, workforce, capital and running costs modelled honestly, with assumptions every stakeholder can challenge.
-
Structure the partnership
Who carries which risk, how payment works, and how quality and access are protected over the life of the contract.
-
Build in compliance
Regulatory pathway, governance and documentation designed in from the start, for every market you intend to enter.
-
Prepare the decision
A clear, documented case that ministries, boards, financiers and regulators can assess on its merits.
We prepare projects for financing and regulatory decisions. Funding, approvals and outcomes remain the decision of the relevant institutions.
Healthcare investment and feasibility
Feasibility studies, financial strategies and economic models that show whether a health project can be built, run and financed.
Health systems and public-private partnerships
Partnership and financing structures that bring capital into health systems while keeping quality, access and accountability in public hands.
Regulatory strategy and market access
Regulatory pathways, compliance-by-design programmes and market-access strategies for pharmaceutical, biotech, MedTech and AI products.
Executive advisory and capability building
Senior advice for leadership teams and practical training in health economics, financing, compliance and market access.
Selected experience
Work led by Dr. Allama Elmehdi across hospital feasibility, local manufacturing, medical-device compliance and regional financing.
- Mauritania, West Africa Making the case for a national mental health hospital Feasibility plan, financial strategy and economic model for Mauritania's first national central mental health hospital.
- Mauritania, West Africa Building a local industry for dialysis products Feasibility plan, financial strategy and economic model for a technology-transfer project to create Mauritania's first manufacturing industry for dialysis products and medical devices.
- United Arab Emirates, GCC Compliance by design for healthcare robotics Compliance and ethics leadership for surgical and humanoid robotics projects in the GCC, aligned with FDA, EU MDR and AI / SaMD requirements.
- Africa Financing organ transplantation across borders Co-author of the Nouakchott Declaration on Organ Donation & Transplantation, presenting a multisectoral financing model for transplant programmes in Africa.
All four describe the founder's professional experience, within the limits of what can be shared publicly.
A physician who speaks the language of finance and regulation
Dr. Allama Elmehdi trained in medicine before turning to health economics. For a decade she has worked where medicine, money and regulation meet, across the GCC, Africa and Europe.
She founded and led a healthcare investment firm in Mauritania, built the economic case for the country's first national mental health hospital, and led compliance for surgical and humanoid robotics projects in the GCC. Today she is GCC Director at the Biotechnology Business Institute Cambridge and a Visiting Research Fellow at United Nations University (UNU-CRIS).
- MD, MBA in Biotechnology, and a postgraduate diploma in health economics and financing
- Co-author of the Nouakchott Declaration on Organ Donation & Transplantation
- Peer reviewer for BMJ Public Health and reviewer for the UK's NIHR
Recent perspectives
From the NexuOneSC for global health newsletter on LinkedIn.
-
A well-governed health PPP is a test of a country's institutional readiness
Why an obvious health need is not the same as an investable project, and what closes the bankability gap between them.
-
What FDA, EU MDR and surgical robotics teach us about responsible scale
AI, software as a medical device and surgical robotics only create clinical value when safety, evidence and accountability are built in from the start.
-
How health financing decisions influence the efficiency of health systems
An executive summary of country experiences from Thailand and Egypt, with global lessons on purchasing, evidence and governance on the road to universal health coverage.
Have a health project that needs to be ready for a decision?
Tell us what you are trying to build, finance or bring to market. Every inquiry is read personally by Dr. Allama Elmehdi.